Is bronchial asthma curable?

Written by Wang Xiang Yu

Pulmonology

Updated on September 16, 2024

00:00

00:00

Bronchial asthma is treatable, although so far we have not found a cure for bronchial asthma, bronchial asthma can be well controlled in most patients if treated in a standard way at regular hospitals, preventing recurrent asthma attacks. However, if the treatment of bronchial asthma is unstandardized, or if one relies on folk remedies or traditional secret recipes and does not receive standardized treatment at a regular hospital, it may lead to recurrent asthma attacks and extremely poor prognosis.

Other Voices

home-news-image

Written by Yuan Qing

Pulmonology

38sec

home-news-image

Characteristics of auscultation for bronchial asthma

Bronchial asthma, commonly known as asthma, is mainly a chronic airway inflammatory disease involving various inflammatory cells and their components. This condition causes the bronchi to narrow and spasm, hindering the passage of air through the airways into the alveoli. Since bronchial asthma primarily affects the smaller bronchi, expiratory wheezes or stridor can often be heard upon auscultation of the trachea. In severe cases, no sounds may be heard from the patient's lungs, a condition referred to as "silent lung," which is an indication of a serious progression of the disease.

home-news-image

Written by Yuan Qing

Pulmonology

51sec

home-news-image

Bronchial asthma X-ray manifestations

Bronchial asthma is primarily caused by inflammation in the airways due to various inflammatory cells, leading to the narrowing and spasm of the bronchi. This impedes the effective expulsion of gases from the lungs through the bronchi, resulting in a disease characterized by symptoms such as wheezing, shortness of breath, chest tightness, and coughing. In patients with bronchial asthma, because of a large amount of gas remaining in the lungs, X-ray manifestations primarily include sparse lung markings, increased translucency, as well as some signs of widened intercostal spaces and lowered diaphragm. Generally, these signs are not specific and cannot be solely relied upon to diagnose or exclude bronchial asthma. It is also necessary to consider the patient's medical history and lung function tests for a comprehensive assessment.

home-news-image

Written by Zeng Xiang Bo

Respiratory and Critical Care Medicine

44sec

home-news-image

Which antibody will increase in bronchial asthma?

Bronchial asthma is a type of chronic allergic inflammation of the airway, commonly referred to as allergic inflammation. Therefore, in laboratory tests, there will be an increase in some antibodies, among which the two main types are the first category being IgE antibodies, which usually exceed 200 IU/ml. The elevation of IgE antibodies indicates that the body is in an allergic state; the other type of antibody is specific antibodies, for example, if I am allergic to fungi, then my fungal antibody levels will be elevated, and if I am allergic to peanuts, then testing for specific peanut antibodies will show an increase. Thus, it is a type of specific antibody that indicates an allergy to certain substances.

home-news-image

Written by Wang Xiang Yu

Pulmonology

48sec

home-news-image

Is bronchial asthma contagious?

Is bronchial asthma contagious? Bronchial asthma is not contagious; it is not an infectious disease. The exact causes of bronchial asthma are not very clear, primarily thought to be related to genetic and environmental factors. Bronchial asthma has a close relationship with genetics, meaning that if parents have asthma, their children and grandchildren might also develop bronchial asthma. The closer the familial relationship, the higher the chances of developing bronchial asthma compared to the general population. This genetic pattern can create the illusion to the general public that bronchial asthma is contagious, but it may be more closely related to genetics.

home-news-image

Written by Wang Li Bing

Intensive Care Medicine Department

38sec

home-news-image

How to treat bronchial asthma?

After the onset of bronchial asthma, it is necessary to carry out active treatment. In clinical practice, the following categories of bronchodilator drugs are mainly used: The first is adrenergic receptor agonists, such as salbutamol and terbutaline; the second is anticholinergic drugs, mainly tiotropium bromide; the third category is xanthine drugs, which can include aminophylline or doxophylline. Additionally, glucocorticoids can be used for pharmacological treatment. If the patient still has recurrent attacks after systemic treatment, hospitalization is recommended for further management.